QLT’s Atrigel licensed for addiction treatment

FORT COLLINS – The continued divesture of QLT USA’s assets has opened the door for a new pharmaceutical employer in Fort Collins.

QLT inked a deal with Reckitt Benckiser Pharmaceutical Inc. to exclusively license its Atrigel product, a sustained-release drug delivery technology that was formulated by QLT predecessor Atrix Laboratories Inc. As part of the licensing agreement, Reckitt Benckiser will take control of QLT USA’s headquarters in Fort Collins, at 2579 Midpoint Drive, along with 18 of the remaining QLT employees.

Reckitt Benckiser Pharmaceutical is a subsidiary of British product giant Reckitt Benckiser. The company’s offerings are dominated by household and personal…